Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response

Krithika N. Kodumudi(Moffitt Cancer Center), Brian J. Czerniecki(Moffitt Cancer Center)
Frontiers in Immunology
August 14, 2019
10.3389/fimmu.2019.01939
Cited by 54

Related Papers

Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
|Frontiers in Immunology|2021|325
Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies
|Oncotarget|2018|33